Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;309(2):e231177.
doi: 10.1148/radiol.231177.

Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials

Takeshi Takahashi  1
Affiliations

Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials

Takeshi Takahashi. Radiology. 2023 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: T.T. No relevant relationships.

Similar articles

See all similar articles

Cited by

References

    1. Yilmaz EC , Shih JH , Belue MJ , et al. . Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers . Radiology 2023. ; 307 ( 4 ): e221309 . - PMC - PubMed
    1. US Preventive Services Task Force ; Grossman DC , Curry SJ , et al. . Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement . JAMA 2018. ; 319 ( 18 ): 1901 – 1913 . [Published correction appears in JAMA 2018;319(23):2443.] - PubMed
    1. Fenton JJ , Weyrich MS , Durbin S , Liu Y , Bang H , Melnikow J . Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force . Rockville (MD) : Agency for Healthcare Research and Quality (US) ; May 2018. . Report No.: 17-05229-EF-1. https://pubmed.ncbi.nlm.nih.gov/30085502/. Accessed October 17, 2023. - PubMed
    1. Horton RH , Dunlop MG , Houlston RS , et al. . Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis . Br J Cancer 2023. ; 128 ( 1 ): 1 – 2 . - PMC - PubMed
    1. Takahashi T . Prostate-Specific Antigen Screening Should Not Be Covered by Publicly Funded Health Insurance . JAMA Oncol 2023. . 10.1001/jamaoncol.2023.0254. Published online April 13, 2023. - DOI - PubMed

Substances

LinkOut - more resources